GlassScriptPhysician profile
Rachel M Harris
NPI 1225499866
$769.66
in general payments reported to CMS, 2019-2025
16 companies · $86.93 in 2025
The $86.93 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $364 · 2022: $33.98 · 2024: $285 · 2025: $86.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $213.12 | 2021-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $118.13 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.58 | 2021-2024 | Jardiance |
| Abbvie INC. | $83.23 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.13 | 2021 | |
| Glaxosmithkline, LLC. | $37.50 | 2024 | Bexsero, Shingrix, Arexvy |
| Boston Scientific Corporation | $33.98 | 2022 | |
| Mylan Specialty L.P. | $29.63 | 2021 | |
| Exact Sciences Corporation | $16.19 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $14.68 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.53 | 2024 | Zoryve |
| Janssen Pharmaceuticals, INC | $14.43 | 2021 | |
| Grifols USA, LLC | $13.46 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $12.88 | 2021 | |
| Eisai INC. | $12.11 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $9.08 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.